Charles Schwab Investment Management Inc. Has $32.85 Million Position in Amedisys, Inc. (NASDAQ:AMED)

Charles Schwab Investment Management Inc. lifted its stake in Amedisys, Inc. (NASDAQ:AMED) by 4.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 361,812 shares of the health services provider’s stock after acquiring an additional 15,730 shares during the quarter. Charles Schwab Investment Management Inc. owned approximately 1.10% of Amedisys worth $32,849,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. SRS Capital Advisors Inc. raised its stake in shares of Amedisys by 2,298.2% during the 4th quarter. SRS Capital Advisors Inc. now owns 1,319 shares of the health services provider’s stock worth $120,000 after purchasing an additional 1,264 shares in the last quarter. US Bancorp DE raised its position in Amedisys by 5.7% during the fourth quarter. US Bancorp DE now owns 3,916 shares of the health services provider’s stock valued at $356,000 after acquiring an additional 210 shares in the last quarter. Amalgamated Bank lifted its stake in Amedisys by 2.9% in the fourth quarter. Amalgamated Bank now owns 15,593 shares of the health services provider’s stock valued at $1,416,000 after acquiring an additional 444 shares during the last quarter. Bank of New York Mellon Corp boosted its holdings in Amedisys by 22.6% in the fourth quarter. Bank of New York Mellon Corp now owns 298,870 shares of the health services provider’s stock worth $27,134,000 after purchasing an additional 55,073 shares in the last quarter. Finally, South Dakota Investment Council boosted its stake in shares of Amedisys by 5.2% during the 4th quarter. South Dakota Investment Council now owns 50,841 shares of the health services provider’s stock worth $4,616,000 after acquiring an additional 2,500 shares in the last quarter. 94.36% of the stock is currently owned by hedge funds and other institutional investors.

Amedisys Stock Performance

AMED opened at $92.57 on Monday. Amedisys, Inc. has a 12-month low of $82.15 and a 12-month high of $98.95. The firm has a market capitalization of $3.04 billion, a P/E ratio of 36.73, a price-to-earnings-growth ratio of 1.78 and a beta of 0.76. The stock’s 50 day moving average price is $92.14 and its two-hundred day moving average price is $92.75. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05.

Amedisys (NASDAQ:AMED) last released its earnings results on Wednesday, February 26th. The health services provider reported $0.96 EPS for the quarter, missing the consensus estimate of $1.05 by ($0.09). The company had revenue of $598.05 million for the quarter, compared to analyst estimates of $602.38 million. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. On average, equities analysts forecast that Amedisys, Inc. will post 4.4 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Separately, Stephens reaffirmed an “equal weight” rating and set a $101.00 target price on shares of Amedisys in a research report on Tuesday, March 4th. Five equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, Amedisys presently has a consensus rating of “Hold” and a consensus price target of $100.75.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.